Clinical trials
Acquired Immunodeficiency Syndrome trials in Nigeria
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
25 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 2 |
| 2009 | 1 |
| 2010 | 1 |
| 2013 | 1 |
| 2017 | 4 |
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 5 |
| 2022 | 1 |
| 2023 | 1 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 15 |
| Terminated | 4 |
| Recruiting | 2 |
| Unknown status | 2 |
| Active, not recruiting | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| FHI 360 | 4 |
| Washington University School of Medicine | 3 |
| Kirby Institute | 2 |
| University of Maryland, Baltimore | 2 |
| Vanderbilt University Medical Center | 2 |
| Dr. Dike Ojji | 1 |
| Elim Pediatric Pharmaceuticals Inc. | 1 |
| Harvard School of Public Health (HSPH) | 1 |
| Instituto Nacional de Salud Publica, Mexico | 1 |
| Liverpool School of Tropical Medicine | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Acquired Immunodeficiency Syndrome | 25 |
| HIV Infections | 3 |
| Sexually Transmitted Diseases | 3 |
| COVID-19 | 2 |
| Hypertension | 2 |
| Albuminuria | 1 |
| Cardiovascular Diseases | 1 |
| Chlamydia Infections | 1 |
| Coronavirus Infections | 1 |
| Genetic Predisposition to Disease | 1 |
Trials
Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.